References

Cure Arthritis Naturally

Beat Arthritis Naturally

Get Instant Access

1. Cheng TO. Some historical notes on Behget's disease. Chest 2001; 119:667-668.

2. Adamantiades B. A case of relapsing iritis with hypopyon (in Greek). Archia Iatrikis Etairias (Proceedings of the Medical Society of Athens) 1930; 586-593.

3. Behget H. Uber rezidivierende, aphthose durch ein virus verursachte geschwure am mund, am auge und an der genitalen. Dermatologische Wochenschrift 1937; 105:1152-1157.

4. Sakane T, Takeno M, Suzuki N, et al. Behget's disease. N Engl J Med 1999; 341(17): 1284-1291.

5. Garton RA, Ghate JV, Jorizzo JL. Behget's disease. In: Harris ED, Budd RC, Firestein GS, et al., eds. Kelly's Textbook of Rheumatology. 7th ed. Philadelphia: Elsevier Science, 2005: 1396-1401.

6. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behget's disease. Adv Exp Med Biol 2003; 528:161-171.

7. Direskeneli H. Behget's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001; 60:996-1002.

8. Navarro S, Ricart JM, Medina P, et al. Activated protein C levels in Behget's disease and risk of venous thrombosis. Br J Haematol 2004; 126(4):550-556.

9. Musabak U, Baylan O, Cetin T, et al. Lipid profile and anticardiolipin antibodies in Behget's disease. Arch Med Res 2005; 36(4):387-392.

10. Yurdakul S, Hamuryudan V, Yazici H. Behget syndrome. Curr Opin Rheumatol 2004; 16(1):38-42.

11. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003; 21(4 suppl 30):S35-S37.

12. Salvarani C, Boiardi L, Casali B, et al. Vascular endothelial growth factor gene polymorphisms in Behget's disease. J Rheumatol 2004; 31(9):1785-1789.

13. Salvarani C, Boiardi L, Casali B, et al. Endothelial nitric oxide synthase gene polymorphisms in Behget's disease. J Rheumatol 2002; 29(3):535-540.

14. Kansu T, Kadayifcilar S. Visual aspects of Behget's disease. Curr Neurol Neurosci Rep 2005; 5(5):382-388.

15. Serdaroglu P. Behget's disease and the nervous system. J Neurol 1998; 245(4):197-205.

16. Erkan F, Gul A, Tasali E. Pulmonary manifestations of Behget's disease. Thorax 2001; 56(7): 572-578. [Comment in Thorax 2002; 57(5):469-470.]

17. www.eyetext.net

18. Kikuchi I. The effects of walnuts on Behget's syndrome in two sisters. J Dermatol 1985; 12(3):290-291.

19. Marquardt JL, Snyderman R, Oppenheim JJ. Depression of lymphocyte transformation and exacerbation of Behget's syndrome by ingestion of English walnuts. Cell Immunol 1973; 9(2): 263-272.

20. Soy M, Erken E, Konca K, et al. Smoking and Behget's disease. Clin Rheumatol 2000; 19(6): 508-509.

21. Firestein GS, Gruber HE, Weisman MH, et al. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behget's disease. Am J Med 1985; 79(1):65-72.

22. http://www.dermnetnz.org

23. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behget's disease: evaluation of 200 patients. The Neuro-Behget Study Group. Brain 1999; 122(11):2171-2182.

24. Raz I, Okon E, Chajek-Shaul T. Pulmonary manifestations in Behget's syndrome. Chest 1989; 95:585-589.

25. Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Behget disease: a cumulative analysis. Chest 2005; 127(6):2243-2253.

26. Tunaci M, Ozkorkmaz B, Tunaci A, et al. CT findings of pulmonary artery aneurysms during treatment for Behget's disease. Am J Roentgenol 1999; 172(3):729-733.

27. Erkan D, Yazici Y, Sanders A, et al. Is Hughes-Stovin syndrome Behget's disease? Clin Exp Rheumatol 2004; 22(4 suppl 34):S64-S68.

28. Kaklamani VG, Nikolopoulou N, Sotsiou F, et al. Renal involvement in Adamantiades-Behget's disease. Case report and review of the literature. Clin Exp Rheumatol 2001; 19(5 suppl 24): S55-S58.

29. Vaiopoulos G, Pangratis N, Samarkos M, et al. Nailfold capillary abnormalities in Behget's disease. J Rheumatol 1995; 22(6):1108-1111.

30. International Study Group for Behget's Disease. Criteria for the diagnosis of Behget's Disease. Lancet 1990; 335(8697):1078-1080.

31. Saglam K, Yilmaz MI, Saglam A, et al. Levels of circulating intracellular adhesion molecule-1 in patients with Behget's disease. Rheumatol Int 2002; 21(4):146-148.

32. Hamuryudan V, Mat C, Saip S, et al. Thalidomide in the treatment of the mucocutaneous lesions of Behget's syndrome. A randomized double-blinded, placebo controlled trial. Ann Intern Med 1998; 128(6):443-450.

33. Zouboulis CC, Orfanos CE. Treatment of Adamantiades-Behget disease with systemic interferon alpha. Arch Dermatol 1998; 134(8):1010-1016.

34. Sfikakis PP. Behget's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002; 61 (suppl 2):ii51-ii53.

35. Tugal-Tutkun I, Mudun A, Urgancioglu M, et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behget's disease: an open-label trial. Arthritis Rheum 2005; 52(8):2478-2484.

36. Ohno S, Nakamura S, Hori S, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behget's disease with refractory uveoretinitis. J Rheumatol 2004; 31(7):1362-1368.

37. Sarwar H, McGrath H Jr, Espinoza LR. Successful treatment of long-standing neuro-Behget's disease with infliximab. J Rheumatol 2005; 32(1):181-183.

38. Yazici H, Basaran G, Hamuryudan V, et al. The ten-year mortality in Behget's syndrome. Br J Rheumatol 1996; 35(2):139-141.

39. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behget syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82(l):60-76.

40. Deuter CM, Kotter I, Gunaydin I, et al. Ocular involvement in Behget's disease: first 5-year results for visual development after treatment with interferon alpha-2a [German]. Opthalmologe 2004; 101 (2):129-134.

41. Kotter I, Gunaydin I, Zierhut M, et al. The use of interferon alpha in Behget's disease: review of the literature. Semin Arthritis Rheum 2004; 33(5):320-335.

Was this article helpful?

0 0
Osteoarthritis

Osteoarthritis

Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook


Post a comment